Hung Trinh: Optimizing the post-CAR T monitoring period in recipients of Axi-cel, Tisa-cel, and Liso-cel by Nausheen Ahmed et al.

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Mel Mann: Helping others have fact-based knowledge of clinical trials and access to them

Razelle Kurzrock: Targeting NRg1 fusions

SER-155 has received Breakthrough Therapy Designation from the FDA – Seres Therapeutics

Aakash Desai: A Year of Remarkable Progress in Lung Cancer and Mesothelioma Treatments

Immunovia Announced Major Milestone in Early-Stage Pancreatic Cancer Detection

FDA approves durvalumab for limited-stage small cell lung cancer

FDA Grants Accelerated Approval to Zenocutuzumab-zbco for NSCLC and Pancreatic Adenocarcinoma

Zhaohui Su: Embracing Real-World Data to Power Rare Cancer Research